首页> 美国卫生研究院文献>Cell Death Disease >Kinesin light chain 4 as a new target for lung cancer chemoresistance via targeted inhibition of checkpoint kinases in the DNA repair network
【2h】

Kinesin light chain 4 as a new target for lung cancer chemoresistance via targeted inhibition of checkpoint kinases in the DNA repair network

机译:驱动蛋白轻链4通过靶向修复DNA修复网络中的检查点激酶成为肺癌化学耐药性的新靶标

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cell viability was measured every 12 h after treatment with 10 μM cisplatin. Death of cells treated with or without 10 μM cisplatin during 12 h intervals. After cisplatin treatment for 24 h, the cells were fixed with 4% paraformaldehyde and immunostained using an antibody targeting γH2AX (DNA damage marker); DNA was visualized using DAPI staining. Protein levels of KLC4, cleaved PARP, and active caspase-3 were determined using western blotting after cisplatin treatment. – Cells treated with etoposide, gefitinib, or Taxol, respectively. Twenty-four hours after the drug treatments, the cells were analyzed using cell viability assay, followed by ELISA.
机译:用10μm的顺铂处理后每隔12h测量一次细胞活力。用或不用10μm顺铂处理的细胞在12h间隔内死亡。顺铂处理24小时后,将细胞用4%多聚甲醛固定,并使用靶向γH2AX的抗体(DNA损伤标记)进行免疫染色;使用DAPI染色将DNA可视化。顺铂处理后,使用蛋白质印迹法测定了KLC4,裂解的PARP和活性caspase-3的蛋白水平。 –分别用依托泊苷,吉非替尼或紫杉醇处理的细胞。药物处理后二十四小时,使用细胞活力测定法分析细胞,然后进行ELISA分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号